Information produit

Exogen logo

EXOGEN – Consolidation* plus rapide des fractures

Le système de consolidation osseuse par ultrasons EXOGEN utilise des ultrasons sécuritaires et indolores pour activer les cellules situées à proximité de la fracture, ce qui stimule le processus de guérison naturel du corps1 et aide les os fracturés à se réparer. Pour le traitement des fractures EXOGEN peut représenter une alternative rentable aux options plus invasives.

Il a été démontré que EXOGEN guérit 86 % des fractures non consolidées qui refusent de se consolider2.  Les fractures fraîches peuvent prendre plusieurs semaines pour guérir, retardant ainsi le retour des patients à leur vie quotidienne. Des études cliniques ont démontré qu’il accélère de 38 % la guérison d’une fracture du tibia ou du radius indiquée* pour ce traitement3,4.

Pour obtenir plus de renseignements, y compris les renseignements posologiques complets et la recherche clinique, visitez le

  1. Azuma Y, Ito M, Harada Y, Takagi H, Ohta T, Jingushi S. Low-intensity pulsed ultrasound accelerates rat femoral fracture healing by acting on the various cellular reactions in the fracture callus. J Bone Miner Res. 2001;16(4):671-680.
  2. Nolte PA, van der Krans A, Patka P, Janssen IM, Ryaby JP, Albers GH. Low-intensity pulsed ultrasound in the treatment of nonunions. J Trauma. 2001;51(4):693-703.
  3. Heckman JD, Ryaby JP, McCabe J, Frey JJ, Kilcoyne RF. Acceleration of tibial fracture-healing by non-invasive, low-intensity pulsed ultrasound. J Bone Joint Surg Am. 1994;76(1):26-34.
  4. Kristiansen TK, Ryaby JP, McCabe J, Frey JJ, Roe LR. Accelerated healing of distal radial fractures with the use of specific, low-intensity ultrasound. A multicenter, prospective, randomized, double-blind, placebo-controlled study. J Bone Joint Surg Am. 1997;79(7):961-73.

*EXOGEN Summary of Indications for Use: The EXOGEN Ultrasound Bone Healing System is indicated for the non-invasive treatment of established non-unions† excluding skull and vertebra. In addition, EXOGEN is indicated for accelerating the time to a healed fracture for fresh, closed, posteriorly displaced distal radius fractures and fresh, closed or Grade I open tibial diaphysis fractures in skeletally mature individuals when these fractures are orthopaedically managed by closed reduction and cast immobilization.

There are no known contraindications for the EXOGEN device. Safety and effectiveness has not been established for individuals lacking skeletal maturity; pregnant or nursing women; patients with cardiac pacemakers; on fractures due to bone cancer; or on patients with poor blood circulation or clotting problems. Some patients may be sensitive to the ultrasound gel. Visit www.exogen.com for full prescribing information or to contact customer service.

†A non-union is considered to be established when the fracture site shows no visibly progressive signs of healing.

BITS, Bioness, L300 Go, H200 Wireless, Vector Gait and Safety System are registered trademarks of Bioness, Inc. Bioventus and EXOGEN are registered trademarks of Bioventus.